SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 41 filers reported holding SOLENO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,675,000 | -20.4% | 9,436,512 | 0.0% | 0.08% | -9.7% |
| Q1 2022 | $2,104,000 | -47.5% | 9,436,512 | -3.4% | 0.09% | -34.0% |
| Q4 2021 | $4,004,000 | -55.6% | 9,765,129 | 0.0% | 0.14% | -50.5% |
| Q3 2021 | $9,028,000 | -18.9% | 9,765,129 | 0.0% | 0.28% | -9.8% |
| Q2 2021 | $11,132,000 | +13.0% | 9,765,129 | +24.9% | 0.32% | +9.7% |
| Q1 2021 | $9,849,000 | -35.2% | 7,816,729 | -0.7% | 0.29% | -38.9% |
| Q4 2020 | $15,192,000 | -18.5% | 7,871,356 | +6.0% | 0.47% | -17.4% |
| Q3 2020 | $18,640,000 | +13.1% | 7,426,368 | 0.0% | 0.57% | +14.7% |
| Q2 2020 | $16,487,000 | +61.9% | 7,426,368 | +73.6% | 0.50% | +30.4% |
| Q1 2020 | $10,181,000 | -19.1% | 4,277,923 | 0.0% | 0.38% | -1.6% |
| Q4 2019 | $12,577,000 | – | 4,277,923 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $22,769,000 | 6.37% |
| CVI Holdings, LLC | 1,550,960 | $3,443,000 | 1.28% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,670,384 | $8,148,000 | 1.03% |
| Trellus Management Company, LLC | 366,432 | $813,000 | 0.88% |
| AWM Investment Company, Inc. | 1,550,000 | $3,441,000 | 0.60% |
| Samsara BioCapital, LLC | 750,000 | $1,665,000 | 0.54% |
| Nantahala Capital Management | 7,426,368 | $16,487,000 | 0.50% |
| Consonance Capital Management LP | 3,040,000 | $6,749,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,233,676 | $2,739,000 | 0.26% |
| Granite Point Capital Management, L.P. | 2,200,000 | $4,884,000 | 0.25% |